Rchr
J-GLOBAL ID:201101085132854710   Update date: Feb. 14, 2024

Hayakawa Fumihiko

ハヤカワ フミヒコ | Hayakawa Fumihiko
Affiliation and department:
Job title: Professor
Other affiliations (2):
Research field  (1): Pharmaceuticals - chemistry and drug development
Research keywords  (7): Drug screening ,  Genetic analysis ,  Pathophysiological analysis ,  Multi-agent clinical trial ,  Clinical trial ,  Malignant lymphoma ,  Leukemia
Research theme for competitive and other funds  (17):
  • 2018 - 現在 ALLにおける新規高頻度融合遺伝子の白血病化メカニズムの解明
  • 2017 - 現在 AYA世代急性リンパ性白血病の小児型治療法および遺伝子パネル診断による層別化治療に関する研究 課題番号: 17ck0106331h0001
  • 2021 - 2024 分化誘導型アイソフォーム誘導療法によるMEF2D融合遺伝子陽性白血病治療
  • 2020 - 2023 フィラデルフィア染色体陽性急性リンパ性白血病に対するポナチニブを組み込んだ治療法の確立と分子基盤の解明
  • 2019 - 2022 小児から成人をシームレスに対象とした B前駆細胞性急性リンパ性白血病に対する前方視的臨床試験による標準治療の開発研究
Show all
Papers (73):
  • Shinichi Kako, Fumihiko Hayakawa, Kiyotoshi Imai, Junji Tanaka, Shuichi Mizuta, Satoshi Nishiwaki, Heiwa Kanamori, Junichi Mukae, Yukiyasu Ozawa, Tadakazu Kondo, et al. Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy. International journal of hematology. 2021. 114. 5. 608-619
  • Takahiko Yasuda, Masashi Sanada, Masahito Kawazu, Shinya Kojima, Shinobu Tsuzuki, Hiroo Ueno, Eisuke Iwamoto, Yuka Iijima-Yamashita, Tomomi Yamada, Takashi Kanamori, et al. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations. Blood. 2021. 139. 12. 1850-1862
  • Sugiura I, Doki N, Hata T, Cho R, Ito T, Suehiro Y, Tanaka M, Kako S, Matsuda M, Yokoyama H, et al. Dasatinib-based Two-step Induction for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Blood advances. 2021
  • Yuri Hayakawa, Shogo Tamura, Nobuaki Suzuki, Koya Odaira, Mahiru Tokoro, Fumika Kawashima, Fumihiko Hayakawa, Akira Takagi, Akira Katsumi, Atsuo Suzuki, et al. Essential role of a carboxyl-terminal α-helix motif in the secretion of coagulation factor XI. Journal of thrombosis and haemostasis : JTH. 2021. 19. 4. 920-930
  • Takeshi Saito, Yoshihiro Hatta, Fumihiko Hayakawa, Tsutomu Takahashi, Maki Hagihara, Hiroatsu Iida, Koichiro Minauchi, Etsuko Yamazaki, Isamu Sugiura, Tohru Murayama, et al. Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group. International journal of hematology. 2021. 113. 3. 395-403
more...
MISC (52):
more...
Lectures and oral presentations  (6):
  • Treatment of acute lymphoblastic leukemia in adolescent and young adult by pediatric protocols.
    (2016)
  • New molecular targets of B-cell acute lymphoblastic leukemia
    (2016)
  • Genetic abnormalities of AYA ALL and its treatment strategy by pediatric like protocols.
    (2016)
  • Adolescent and young adult (AYA)世代の急性リンパ性白血病
    (第77回日本血液学会学術集会 2015)
  • AYA ALL に対する小児プロトコールの有効性と認容の検討:JALSG ALL202-U 研究より
    (第56回日本小児血液・がん学会学術集会シンポジウム 2014)
more...
Education (1):
  • 1987 - 1993 Nagoya University Faculty of Medicine
Professional career (1):
  • 医学博士 (名古屋大学)
Work history (12):
  • 2020/04/01 - 現在 Nagoya University Graduate School of Medicine Professor
  • 2018/04/01 - 現在 Nagoya University Graduate School of Medicine, Department of Radiological and Medical Laboratory Sciences
  • 2016/05/01 - 現在 Nagoya University Hospital, Hospital
  • 2018/04/01 - 2020/03/31 Nagoya University Graduate School of Medicine Department of Radiological and Medical Laboratory Sciences Pathophysiological Laboratory Sciences Professor
  • 2015/05/01 - 2018/03/31 Nagoya University Nagoya University Hospital Hematology Lecturer
Show all
Awards (1):
  • 2006 - 上原記念生命科学財団 上原記念生命科学財団 研究奨励金
Association Membership(s) (3):
日本内科学会 ,  日本癌学会 ,  日本血液学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page